Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study

Title

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study

Identifier

/unibl/sci/idNaucniRad:24182
616.36-002(497.6RS)
info:doi/10.5937/scriptamed50-22255

Type

See all items with this valuetext
See all items with this valueAcademic Article

Date

See all items with this value2019-02

Bibliographic Citation

A. Verhaz, Z. Kezić, R. Škrbić, M. Stoiljković, Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study, Scripta Medica, Vol. 50, No. 3, pp. 77 - 81, Feb, 2019

page start

77

page end

81

Is Part Of

See all items with this valueScripta Medica
See all items with this valueISSN 2490

list of authors

See all items with this valueAntonija Verhaz
See all items with this valueZdravka Kezić
See all items with this valueRanko Škrbić
See all items with this valueMiloš Stoiljković